Evogene (NASDAQ:EVGN), a leader in computational chemistry and generative AI for life sciences, announced the appointment of Dr. Olga Nissan as Vice President of Business Development, effective Jan. 1, 2026.
REE Automotive (NASDAQ:REE) reported financial results for the six months ended June 30, 2025, highlighting a strategic shift toward a technology-first and OEM-collaboration model as the company continues to develop its electric vehicle platform.
EUDA Health Holdings (NASDAQ:EUDA) has unveiled a nationwide stem cell extraction, cryostorage, and clinical delivery platform in China, marking a massive expansion of its footprint in the regional longevity and regenerative medicine sector.
Bridger Aerospace Group Holdings (NASDAQ:BAER) has finalized the acquisition of six additional aircraft, a strategic expansion that solidifies its position as the owner of the world’s largest private "Super Scooper" fleet ahead of the 2026 wildfire season.
Tesla (NASDAQ:TSLA) is expected to report its second consecutive annual decline in vehicle deliveries this Friday, as the loss of critical U.S. tax credits and a surge in global competition outweigh the recent launch of its most affordable models.
Euro Tech Holdings (NASDAQ:CLWT) reported unaudited results for the six months ended June 30, 2025, showing a decline in revenue and a return to net loss, reflecting challenges in U.S.–China trade relations.
T1 Energy (NYSE:TE) has successfully monetized $160 million of Section 45X production tax credits (PTCs), providing a significant non-dilutive capital injection to accelerate its build-out of a domestic solar supply chain.
CBL International Limited (NASDAQ:BANL) reached a major operational milestone on Tuesday, completing the first-ever liquefied natural gas (LNG) bunkering operation at Xiaomo Port in Shenzhen.
MetLife Investment Management (MIM), the institutional asset management arm of MetLife (NYSE:MET), has finalized its acquisition of PineBridge Investments, significantly expanding its global footprint and total assets under management to $734.7 billion.
HUTCHMED (NASDAQ:HCM) announced on Tuesday that Chinese regulators have accepted its New Drug Application (NDA) for savolitinib and granted it priority review, clearing a path for the drug to become the first selective MET inhibitor approved for gastric cancer in the region.
Meta Platforms (NASDAQ:META) has agreed to acquire Manus, a Singapore-based startup whose autonomous AI agents became a Silicon Valley sensation earlier this year.
Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY) have begun an aggressive price-cutting campaign for their blockbuster obesity treatments in China, as the two pharmaceutical giants race to capture the world's largest patient population before local generic competition arrives.
